Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Just a few hours left in 3Q
View:
Post by Beano349 on Sep 30, 2024 6:36pm

Just a few hours left in 3Q

....or just another fake timeline.
Comment by Oilminerdeluxe on Oct 01, 2024 12:49am
Beano, if memory recalls, they did not announce pre-BTD last time they sent it to the FDA. No reason to believe they will tell us now either. If they choose to tell us, fine. But unless the powers that be has desired additional info of some kind, there is every reason to believe they will send it in now. Then, unless they get told other info/data is needed first, actual BTD- application should ...more  
Comment by StevenBirch on Oct 01, 2024 8:02am
That's right, I don't think applications are news but responses are. I don't even know if a response to a pre-BTD submission is news whereas one to the formal BTD obviously would be. It's just my opinion but the only material news is the response from the FDA to a formal BTD submission and any other news release could just lead to the price being manipualted in the short term. Now ...more  
Comment by Beano349 on Oct 01, 2024 8:12am
They are over a year delayed.  I think being ok with the status quo as passed. 
Comment by Dumbeldorfwhite on Oct 01, 2024 8:44am
Vote them out.
Comment by managementfirst on Oct 01, 2024 9:50am
As a long time shares holder, often feel frustrated like everone here. But considering Theralase is such a small company devoting to a revolutionary cancer cure method, never be easy to success. I still keep confidence and want to wait further. I never think RTW and his fellows working hard. 
Comment by managementfirst on Oct 01, 2024 9:53am
Sorry, I always believe RTW and his fellows working hard though timeline was broken. Some thing is not decided by himself.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250